Cameco Corporation (NYSE:CCJ) Receives Average Rating of “Moderate Buy” from Brokerages

Cameco Corporation (NYSE:CCJ) (TSE:CCO) has been given a consensus rating of “Moderate Buy” by the sixteen research firms that are covering the stock, MarketBeat reports. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $148.62.

A number of analysts recently weighed in on the stock. William Blair assumed coverage on shares of Cameco in a report on Monday, April 20th. They set an “outperform” rating on the stock. Zacks Research lowered shares of Cameco from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 18th. Scotiabank reissued an “outperform” rating and issued a $175.00 price target on shares of Cameco in a research note on Wednesday, May 6th. Barclays assumed coverage on shares of Cameco in a report on Thursday, May 21st. They issued an “equal weight” rating and a $108.00 price target on the stock. Finally, Weiss Ratings lowered shares of Cameco from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, June 4th.

Cameco Stock Performance

Cameco stock opened at $94.94 on Thursday. The firm’s 50 day simple moving average is $113.52 and its 200 day simple moving average is $109.01. The company has a current ratio of 3.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $41.35 billion, a PE ratio of 87.91, a price-to-earnings-growth ratio of 1.73 and a beta of 0.99. Cameco has a 1-year low of $64.19 and a 1-year high of $135.24.

Cameco (NYSE:CCJ) (TSE:CCO) last posted its earnings results on Tuesday, May 5th. The basic materials company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.05. The business had revenue of $607.49 million for the quarter, compared to analyst estimates of $598.63 million. Cameco had a net margin of 18.38% and a return on equity of 11.05%. Cameco’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.16 EPS. As a group, analysts expect that Cameco will post 1.31 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cameco

Institutional investors have recently made changes to their positions in the stock. Nisa Investment Advisors LLC bought a new position in shares of Cameco in the 4th quarter worth $25,000. Founders Capital Management bought a new position in shares of Cameco in the 4th quarter worth $27,000. Strategic Advocates LLC bought a new position in shares of Cameco in the 3rd quarter worth $28,000. Mcguire Capital Advisors Inc. bought a new position in shares of Cameco in the 4th quarter worth $28,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Cameco by 30,700.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 308 shares of the basic materials company’s stock worth $28,000 after buying an additional 307 shares during the last quarter. Institutional investors own 70.21% of the company’s stock.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.